Almirall is awarded the “Prince Felipe Prize for Business Competitiveness for Large Enterprises” from the Ministry of Industry
This is the second time Almirall has won this prize, the first being the prize for Technological Innovation in 1994.
The Prince Felipe Prizes are awarded in a total of nine categories, with the award for Business Competitiveness – for both large companies and SMEs – a step above the rest since it evaluates all the competitive factors that are encompassed in each of the other areas awarded: Industrial Quality, Design, Technological Innovation, Internationalisation, the Tourism Industry, the Information Society and Information and Communication Technologies, Renewable Energies and Energy Efficiency, and Top Brand Management.
The prize has been awarded to Almirall for its ongoing, exemplary efforts in the research and technological development of new medicines, for being a leader in its therapeutic areas, and for its investment endeavour in R&D, which has shown a spectacular increase in the years 2003 and 2004.
According to the jury’s statement, the 9th edition of the Prince Felipe Prize for Business Competitiveness was awarded to Almirall due to “its process of internationalisation based on the establishment of subsidiaries outside Spain and on its licensing agreements for its own internally-researched products; its implementation of an effective human resources policy, creating new positions within the working organisation as elements of cohesion between Corporate Management and the other areas; and its implementation of a new method of reorganising the production system based on trust”.
The Prince Felipe Prize awards ceremony took place on 18th November at the National Music Auditorium in Madrid, and dignitaries attending included Their Royal Highnesses the Prince and Princess of Asturias, Don Felipe de Borbón and Doña Letizia Ortiz, and the Minister of Industry, Trade and Tourism, José Montilla, as well as other renowned personages from the worlds of politics, economics and society.
The Prince Felipe Prizes
The Prince Felipe Prizes for Business Excellence have been awarded for eleven years and have become the most prestigious prize granted in recognition of the companies that have most distinguished themselves in
Almirall, the leading Spanish multinational pharmaceutical company
The main aim of Almirall, the leading Spanish multinational pharmaceutical company, is to provide society with innovative drugs to combat discomfort and disease, thus helping to improve health and quality of life. To this end, it constantly devotes the maximum human and financial resources to researching new products.
The company’s main research fields fall within the areas related to the treatment of asthma, COPD, psoriasis, and arthritis rheumatoid.
The company plans to invest some 500 million euros in R&D during the next five years, and the total sales forecasts for 2004 are projected to reach 956 million euros. Its estimated staff for 2004 is 3.321 people, of whom 518 are related to R&D activities.
The company also has four R&D centres and six manufacturing plants, as well as branch offices in the main cities of
Its annual production forecast for this year stands at 88 million units, and products resulting from its own R&D are marketed in over 80 countries around the world. Further information on Almirall is available on the following website: http://www.almirall.es